A broadly cross-reactive monoclonal antibody against an epitope on the n-terminus of meningococcal fHbp.
about
Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other PurposesRole of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseDefining a protective epitope on factor H binding protein, a key meningococcal virulence factor and vaccine antigenBinding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity.A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens.Binding of Complement Factor H (FH) Decreases Protective Anti-FH Binding Protein Antibody Responses of Infant Rhesus Macaques Immunized With a Meningococcal Serogroup B Vaccine.Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C VaccineA meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes.Importance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccinesfH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity.Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates.Meningococcal carriage among a university student population - United States, 2015.Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp.Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes.Molecular characterization of two sub-family specific monoclonal antibodies to meningococcal Factor H binding protein.
P2860
Q26782318-C5AD4C2D-95D7-4BE7-B21B-F4927CE82F8FQ26995760-4E6CDC99-025F-457C-A2DD-B205E2942FD8Q27676318-4082103D-14E8-4FC8-A7E6-938000D18AE4Q35187629-05799A54-B4A1-4E68-9612-3A3FA1C6B108Q35658277-30BA0BAB-24BB-4472-835D-DC83ADF4919AQ35965207-AF93E7DC-6B98-45F1-BD25-9454BF7CC1A8Q36211092-D6E1A44A-5E45-4B7F-A454-8FC8717A3F9BQ36316767-CAF75FBB-D4BF-4F64-9096-DB83D5351E7AQ36354851-FD1C17CC-3F6D-4970-93E0-A83468E67792Q37037083-30FFB008-C18F-4197-AE45-256B1D450D3CQ37130358-FA721A16-D704-4FA3-9C58-D7F134FE2F1FQ37163679-143EBE15-AB77-4C36-A4E2-B20E3AC46033Q38328071-10253A7C-D99F-4332-B528-6D8E4B68BDCFQ47102654-5EB5EFBA-3FF0-42B0-90D0-0DFAAC693B49Q48095992-F6D0F36E-E98D-4FBA-9696-E3FDE4735C10Q52682421-92C54771-452F-4FB3-8F55-A2BBCD855F87Q55266742-BFB1B1C7-785A-4DE6-B343-36BED29C5198
P2860
A broadly cross-reactive monoclonal antibody against an epitope on the n-terminus of meningococcal fHbp.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A broadly cross-reactive monoc ...... erminus of meningococcal fHbp.
@ast
A broadly cross-reactive monoc ...... erminus of meningococcal fHbp.
@en
type
label
A broadly cross-reactive monoc ...... erminus of meningococcal fHbp.
@ast
A broadly cross-reactive monoc ...... erminus of meningococcal fHbp.
@en
prefLabel
A broadly cross-reactive monoc ...... erminus of meningococcal fHbp.
@ast
A broadly cross-reactive monoc ...... erminus of meningococcal fHbp.
@en
P2093
P2860
P356
P1433
P1476
A broadly cross-reactive monoc ...... terminus of meningococcal fHbp
@en
P2093
Dan M Granoff
Donald C Reason
Rolando Pajon
P2860
P2888
P356
10.1038/SREP00341
P407
P50
P577
2012-03-28T00:00:00Z